jm1c00004_si_003.csv (5.24 kB)

Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases

Download (5.24 kB)
dataset
posted on 17.06.2021, 21:00 by Kongjun Liu, Dan Li, Wei Zheng, Mingsong Shi, Yong Chen, Minghai Tang, Tao Yang, Min Zhao, Dexin Deng, Chufeng Zhang, Jiang Liu, Xue Yuan, Zhuang Yang, Lijuan Chen
Guided by molecular docking, a commonly used open-chain linker was cyclized into a five-membered pyrrolidine to lock the overall conformation of the propeller-shaped molecule. Different substituents were introduced into the pyrrolidine moiety to block oxidative metabolism. Surprisingly, it was found that a small methyl substituent could be used to alleviate the oxidative metabolism of pyrrolidine while maintaining or enhancing potency, which could be described as a “magic methyl”. Further optimization around the “3rd blade” of the propeller led to identification of a series of potent and selective PI3Kδ inhibitors. Among them, compound 50 afforded an optimum balance of PK profiles and potency. Oral administration of 50 attenuated the arthritis severity in a dose-dependent manner in a collagen-induced arthritis model without obvious toxicity. Furthermore, 50 demonstrated excellent pharmacokinetic properties with high bioavailability, suggesting that 50 might be an acceptable candidate for treatment of inflammatory diseases.

History